US Venture Partners X LP's Form 4 filing
eFFECTOR Therapeutics, Inc. (EFTR) · filed Dec 6, 2021
- Accession no.
- 0001062993-21-012276
- Filed
- Dec 6, 2021, 7:27 PM ET
- Trade date
- Dec 2, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $46.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| US Venture Partners X LPCIK 0001440514 | 10% Owner |
| Usvp X Affiliates LPCIK 0001453359 | 10% Owner |
| Tansey Casey MCIK 0001474322 | 10% Owner |
| Presidio Management Group X LLCCIK 0001602744 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2021 | Common Stock | SSaleDisposed | −7,861 | $5.68 | −$44,650.48 | 4,384,301 | Indirect | Duplicate filing |
| Dec 2, 2021 | Common Stock | SSaleDisposed | −252 | $5.68 | −$1,431.36 | 140,261 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.